Page last updated: 2024-10-20

uric acid and Hyperlipoproteinemia Type I

uric acid has been researched along with Hyperlipoproteinemia Type I in 1 studies

Uric Acid: An oxidation product, via XANTHINE OXIDASE, of oxypurines such as XANTHINE and HYPOXANTHINE. It is the final oxidation product of purine catabolism in humans and primates, whereas in most other mammals URATE OXIDASE further oxidizes it to ALLANTOIN.
uric acid : An oxopurine that is the final oxidation product of purine metabolism.
6-hydroxy-1H-purine-2,8(7H,9H)-dione : A tautomer of uric acid having oxo groups at C-2 and C-8 and a hydroxy group at C-6.
7,9-dihydro-1H-purine-2,6,8(3H)-trione : An oxopurine in which the purine ring is substituted by oxo groups at positions 2, 6, and 8.

Hyperlipoproteinemia Type I: An inherited condition due to a deficiency of either LIPOPROTEIN LIPASE or APOLIPOPROTEIN C-II (a lipase-activating protein). The lack of lipase activities results in inability to remove CHYLOMICRONS and TRIGLYCERIDES from the blood which has a creamy top layer after standing.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
DODINVAL, P1
AMMANN, F1
KLEIN, D1
MACH, R1

Other Studies

1 other study available for uric acid and Hyperlipoproteinemia Type I

ArticleYear
[CUTANEOUS AND TENDINOUS TUBEROUS XANTHOMATOSIS THROUGH 3 GENERATIONS].
    Journal de genetique humaine, 1964, Volume: 13

    Topics: Angina Pectoris; Blood; Eyelids; Genetics, Medical; Hyperlipidemias; Hyperlipoproteinemia Type I; Hy

1964